The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2024

Filed:

Feb. 27, 2020
Applicant:

Km Biologics Co., Ltd., Kumamoto, JP;

Inventors:

Ryo Yamaue, Kikuchi, JP;

Satoshi Kamakura, Kikuchi, JP;

Mihoko Matsuo, Kikuchi, JP;

Masaharu Torikai, Kikuchi, JP;

Hiroaki Mori, Kikuchi, JP;

Assignee:

KM BIOLOGICS CO., LTD., Kumamoto, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/155 (2006.01); A61P 31/14 (2006.01); C12N 7/00 (2006.01); C12N 15/62 (2006.01);
U.S. Cl.
CPC ...
A61K 39/155 (2013.01); A61P 31/14 (2018.01); C12N 7/00 (2013.01); C12N 15/62 (2013.01);
Abstract

A novel vaccine antigen for prevention of Respiratory Syncytial Virus (RSV) infection is created which surpasses conventional vaccines comprising as an antigen RSV F protein alone in view of efficacy and/or safety. A vaccine is prepared which comprises as an antigen a RSV F/G chimeric protein wherein a portion of RSV F protein as a basic structure is replaced with a whole or a portion of Conserved Central Domain sequence of RSV G protein or wherein a whole or a portion of Conserved Central Domain sequence of RSV G is added to the basic structure. As a result of assessment of both efficacy and safety, a vaccine comprising as an antigen the F/G chimeric protein of the present invention confirmed to be more excellent than a vaccine comprising as an antigen RSV F protein alone in view of efficacy and/or safety.


Find Patent Forward Citations

Loading…